prostate cancer

(redirected from Prostatic cancer)
Also found in: Thesaurus, Medical, Encyclopedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.prostate cancer - cancer of the prostate gland
adenocarcinoma, glandular cancer, glandular carcinoma - malignant tumor originating in glandular epithelium
References in periodicals archive ?
Various therapies are used depending upon the feasibility of prostatic cancer conditions.
Dr Jiang et al then go on to discuss the intriguing story of the so-called translocation renal cell carcinoma, the applications of the UroVysion FISH test in urine cytology, and the still timely subject of triple immunostaining for the diagnosis of prostatic cancer.
Digital rectal examination is the most reliable method of diagnosing prostatic cancer.
Induction of apoptosis in human prostatic cancer cells with 13-glucan (maitake mushroom polysaccharide).
AThe test is PSA or prostate specic antigen, which is raised in some people, though not everyone, who have prostatic cancer.
CYPROTERONE acetate is an anti-androgen therapy which is used in the management of patients with prostatic cancer.
Estrogens are the risk factors in prostatic cancer and their local tissue increase in autoimmune diseases is connected with aggravation of the proliferative complications of these disorders.
twice as likely to develop cancer of the prostate as Caucasian Americans, while South African Blacks are 10 to 30 times less likely to develop prostatic cancer than their American distant cousins and 2 to 10 times less likely than African Whites, who may be presumed to have a mixed European ancestry somewhat similar to that of White Americans?
Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others?
In this paper a case study is presented in which PSA established the diagnosis of metastatic prostatic cancer and provided information on the course of the disease and response to treatment, between 1995 and 2003.
Metabolites from benzyl glucosinolates have been implicated to arrest proliferation from prostatic cancer cell lines (Nachshon-Kedmi et al.